Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk
Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk
About this item
Full title
Author / Creator
Mignot, M. A. , Taisne, N. , Legroux, I. , Cortet, B. and Paccou, J.
Publisher
London: Springer London
Journal title
Language
English
Formats
Publication information
Publisher
London: Springer London
Subjects
More information
Scope and Contents
Contents
Summary
A cohort of 183 postmenopausal women, who had either discontinued or continued bisphosphonates (BPs) after first-line therapy, was used to investigate the relationships between “drug holiday” and clinical fracture. The risk of new clinical fractures was found to be 40% higher in women who had taken a BP “drug holiday.”
Introduction
Alternative Titles
Full title
Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_04445007v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04445007v1
Other Identifiers
ISSN
0937-941X
E-ISSN
1433-2965
DOI
10.1007/s00198-017-4215-9
